News

Gastrointestinal infections were the most common serious infections associated with biologics, according to a cohort analysis.

Andrea Mazzocchi, PhD, explains how tissue and blood samples can be used to improve detection, progression, and treatment for cancer in patients.

Data show while women with GDM wanted to be responsible for their own health, an annual reminder and combined appointments would help to screen for T2D.

On this episode of Coping After COVID, Dr. Craig Chepke discusses the challenges for schizophrenia patients.

Orphaned children experience greater risk of abuse and health complications, prompting a call to action for greater research and management of COVID-19 in ailing countries.

The rare liver disease can often lead to liver failure.

A study notes that irradiation did not impact transfusion requirements or relevant laboratory values among patients receiving chronic blood transfusions.

A leading author of a recent Oxford study speaks of azithromycin, its limitations in treating patients with COVID-19, and the importance of properly utilizing the antibiotic.

Data show no significant difference in survival rates in the canukinumab group (88.8%) compared to placebo (85.7%).

The issuance comes within a week of the planned PDUFA date for the drug's possible indication as an adult CKD therapy.

The researchers found sero-protection rate at 12-month was significantly higher in the ID arm compared to the IM cohort.

More randomized controlled trials are needed to assess their long-term effectiveness, safety, and effects on health-related quality of life.

Using a participant group culled from several countries, investigators believe they have a better understanding on what contributes to uncontrolled allergic rhinitis and what it means for future patient care.

The co-founder and CEO of Known Medicine dissects the art and science of how profiling biomarkers, epigenetics and the microenvironment may provide the synergy needed to revolutionize the oncologic landscape.

Data show total amount of patients pre-guideline was 558,175 compared to 532,962 patients after the release of the guideline.

Second opinions are mutually beneficial for patients and doctors alike, and the availability of a second opinion has become exponentially easier in recent years due to changes in virtual medicine.

In a single-center study, no patients were screened annually for HIV and HCV.

Researchers aimed to establish new treatments for patients with COVID-19, but found no evidence of antiviral benefits or decreases in hospitalization and ventilation rates.

Despite its accessibility and affordability, azithromycin does not positively affect patients with COVID-19, according to a new UK study.

Data show 3 life-threatening adverse events required intervention, but were unrelated to buprenorphine induction.

Upadacitinib has shown promising results for a variety of diseases such as severe atopic dermatitis and psoriatic arthritis, but its future remains uncertain.

The treatment met all 5 primary efficacy endpoints as part of the ASCEND program.

This patient group was at an increased risk for future exposure to systemic corticosteroids and anti-TNF biologics.

Data show risk factors included education level and increased glucose level did not have signficant impact on BMI and body fat of children.

Enrollees with OUD receiving medication treatment increased from 47.8% in 2014 to 57.1% in 2018

The FDA Cardiovascular and Renal Drugs Advisory Committee cited concerns over an increase in thrombotic events.

A new statement from the AHA and American Stroke Association stressed the need to address gaps in care that may lead to high risk of stroke recurrence.

The new kinoid vaccine has shown positive results in mice with human proteins, and the France-based team remain optimistic of human trials in the future.